{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T11:02:18Z","timestamp":1781521338075,"version":"3.54.1"},"update-to":[{"DOI":"10.1002\/14651858.cd004437.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,12,18]],"date-time":"2018-12-18T00:00:00Z","timestamp":1545091200000}}],"reference-count":130,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd004437.pub5","type":"journal-article","created":{"date-parts":[[2018,12,17]],"date-time":"2018-12-17T21:24:02Z","timestamp":1545081842000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Thrombolytic therapy for pulmonary embolism"],"prefix":"10.1002","author":[{"given":"Qiukui","family":"Hao","sequence":"first","affiliation":[{"name":"West China Hospital, Sichuan University; The Center of Gerontology and Geriatrics; No. 37, Guo Xue Xiang Chengdu Sichuan China 610041"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bi Rong","family":"Dong","sequence":"additional","affiliation":[{"name":"West China Hospital, Sichuan University; The Center of Gerontology and Geriatrics; No. 37, Guo Xue Xiang Chengdu Sichuan China 610041"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jirong","family":"Yue","sequence":"additional","affiliation":[{"name":"West China Hospital, Sichuan University; The Center of Gerontology and Geriatrics; No. 37, Guo Xue Xiang Chengdu Sichuan China 610041"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taixiang","family":"Wu","sequence":"additional","affiliation":[{"name":"West China Hospital, Sichuan University; Chinese Clinical Trial Registry, Chinese Ethics Committee of Registering Clinical Trials; No. 37, Guo Xue Xiang Chengdu Sichuan China 610041"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guan J","family":"Liu","sequence":"additional","affiliation":[{"name":"West China Hospital, Sichuan University; Cochrane China; No. 37, Guo Xue Xiang Chengdu Sichuan China 610041"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,12,18]]},"reference":[{"issue":"3","key":"10.1002\/14651858.CD004437.pub5-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1016\/j.thromres.2009.09.017","article-title":"Bolus tenecteplase for right ventricle dysfunction in hemodynamically stable patients with pulmonary embolism","volume":"125","author":"Becattini","year":"2010","journal-title":"Thrombosis Research"},{"issue":"3","key":"10.1002\/14651858.CD004437.pub5-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/0735-1097(92)90002-5","article-title":"PAIMS2: Alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen activator Italian multicenter study 2","volume":"20","author":"Dalla-Volta","year":"1992","journal-title":"Journal of the American College of Cardiology"},{"issue":"1","key":"10.1002\/14651858.CD004437.pub5-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1177\/153857447901300107","article-title":"Streptokinase and heparin in the treatment of major pulmonary embolism: a randomised comparison","volume":"13","author":"Dotter","year":"1979","journal-title":"Vascular Surgery"},{"issue":"1","key":"10.1002\/14651858.CD004437.pub5-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/MAJ.0b013e3181f1fc3e","article-title":"Six-month echocardiographic study in patients with submassive pulmonary embolism and right ventricle dysfunction: comparison of thrombolysis with heparin","volume":"341","author":"Fasullo","year":"2011","journal-title":"American Journal of the Medical Sciences"},{"issue":"8844","key":"10.1002\/14651858.CD004437.pub5-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0140-6736(93)90274-K","article-title":"Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion","volume":"341","author":"Goldhaber","year":"1993","journal-title":"The Lancet"},{"issue":"3","key":"10.1002\/14651858.CD004437.pub5-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/BF01062714","article-title":"Streptokinase and heparin versus heparin alone in massive pulmonary embolism: a randomized controlled trial","volume":"2","author":"Jerjes-S\u00e1nchez","year":"1995","journal-title":"Journal of Thrombosis and Thrombolysis"},{"issue":"10 Suppl 1","key":"10.1002\/14651858.CD004437.pub5-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"E2074","DOI":"10.1016\/S0735-1097(13)62074-4","article-title":"Randomized trial of tenecteplase or placebo with low molecular weight heparin for acute submassive pulmonary embolism: assessment of patient-oriented cardiopulmonary outcomes at three months","volume":"61","author":"Kline","year":"2013","journal-title":"Journal of the American College of Cardiology"},{"issue":"6","key":"10.1002\/14651858.CD004437.pub5-BIB0008|cit8","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/1742-6723.12159","article-title":"Rationale and methodology for a multicentre randomised trial of fibrinolysis for pulmonary embolism that includes quality of life outcomes","volume":"25","author":"Kline","year":"2013","journal-title":"Emergency Medicine Australasia"},{"issue":"5 Suppl 1","key":"10.1002\/14651858.CD004437.pub5-BIB0009|cit9","first-page":"S7","article-title":"Randomized trial of tenecteplase or placebo with low molecular weight heparin for acute submassive pulmonary embolism: assessment of patient-oriented cardiopulmonary outcomes at three months","volume":"20","author":"Kline","year":"2013","journal-title":"Academic Emergency Medicine"},{"issue":"4","key":"10.1002\/14651858.CD004437.pub5-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/jth.12521","article-title":"Treatment of submassive pulmonary embolism with tenecteplase or placebo: cardiopulmonary outcomes at 3 months: multicenter double-blind, placebo-controlled randomized trial","volume":"12","author":"Kline","year":"2014","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"15","key":"10.1002\/14651858.CD004437.pub5-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1056\/NEJMoa021274","article-title":"Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism","volume":"347","author":"Konstantinides","year":"2002","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD004437.pub5-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1161\/CIRCULATIONAHA.113.005544","article-title":"Randomized controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism","volume":"129","author":"Kucher","year":"2014","journal-title":"Circulation"},{"issue":"6","key":"10.1002\/14651858.CD004437.pub5-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1378\/chest.98.6.1473","article-title":"A randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism","volume":"98","author":"Levine","year":"1990","journal-title":"Chest"},{"key":"10.1002\/14651858.CD004437.pub5-BIB0014|cit14","unstructured":"Arnesen BLH Eie H Hol R A prospective study of streptokinase and heparin in the treatment of major pulmonary embolism Acta Medica Scandinavica Supplement 1978 15"},{"issue":"6","key":"10.1002\/14651858.CD004437.pub5-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.0954-6820.1978.tb14909.x","article-title":"A controlled clinical trial of streptokinase and heparin in the treatment of major pulmonary embolism","volume":"203","author":"Ly","year":"1978","journal-title":"Acta Medica Scandinavica"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD004437.pub5-BIB0016|cit16","first-page":"26","article-title":"A controlled clinical trial on the effect of heparin infusion and two regimens of urokinase in acute pulmonary embolism","volume":"14","author":"Giuntini","year":"1984","journal-title":"Giornale Italiano di Cardiologia"},{"issue":"3","key":"10.1002\/14651858.CD004437.pub5-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000195517","article-title":"Fibrinolytic effects of urokinase and heparin in acute pulmonary embolism: a randomized clinical trial","volume":"54","author":"Marini","year":"1988","journal-title":"Respiration"},{"issue":"12","key":"10.1002\/14651858.CD004437.pub5-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/j.jacc.2016.12.039","article-title":"Impact of thrombolytic therapy on the long-term outcome of intermediate-risk pulmonary embolism","volume":"69","author":"Konstantinides","year":"2017","journal-title":"Journal of the American College of Cardiology"},{"issue":"15","key":"10.1002\/14651858.CD004437.pub5-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1056\/NEJMoa1302097","article-title":"Fibrinolysis for patients with intermediate-risk pulmonary embolism","volume":"370","author":"Meyer","year":"2014","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD004437.pub5-BIB0020|cit20","unstructured":"NCT00639743 PEITHO Pulmonary Embolism Thrombolysis Study http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00639743?term=thrombolysis&rank=14 (accessed April 2009)"},{"key":"10.1002\/14651858.CD004437.pub5-BIB0021|cit21","doi-asserted-by":"crossref","unstructured":"PEITHO Steering Committee Single-bolus tenecteplase plus heparin compared with heparin alone for normotensive patients with acute pulmonary embolism who have evidence of right ventricular dysfunction and myocardial injury: rationale and design of the Pulmonary Embolism Thrombolysis (PEITHO) trial American Heart Journal 2012 33 8","DOI":"10.1016\/j.ahj.2011.10.003"},{"issue":"3","key":"10.1002\/14651858.CD004437.pub5-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1378\/chest.97.3.528","article-title":"Tissue plasminogen activator for the treatment of acute pulmonary embolism. A collaborative study by the PIOPED investigators","volume":"97","author":"PIOPED Investigation Committee","year":"1990","journal-title":"Chest"},{"issue":"2","key":"10.1002\/14651858.CD004437.pub5-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.amjcard.2012.09.027","article-title":"Moderate pulmonary embolism treated with thrombolysis (from the \"mOPETT\" Trial)","volume":"111","author":"Sharifi","year":"2013","journal-title":"American Journal of Cardiology"},{"issue":"3","key":"10.1002\/14651858.CD004437.pub5-BIB0024|cit24","first-page":"104","article-title":"Thrombolytic-plus-anticoagulant therapy versus anticoagulant-alone therapy in submassive pulmonary thromboembolism (TVASPE study): a randomized clinical trial","volume":"9","author":"Taherkhani","year":"2014","journal-title":"Journal of Tehran University Heart Center"},{"issue":"904","key":"10.1002\/14651858.CD004437.pub5-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1136\/bmj.1.5904.343","article-title":"Comparison by controlled clinical trial of streptokinase and heparin in treatment of life-threatening pulmonary embolism","volume":"1","author":"Tibbutt","year":"1974","journal-title":"British Medical Journal"},{"issue":"2 Suppl","key":"10.1002\/14651858.CD004437.pub5-BIB0026|cit26","first-page":"7","article-title":"The urokinase pulmonary embolism trial","volume":"47","author":"Sasahara","year":"1973","journal-title":"Circulation"},{"issue":"15","key":"10.1002\/14651858.CD004437.pub5-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1056\/NEJM198010093031502","article-title":"Effect of thrombolytic therapy on pulmonary-capillary blood volume in patients with pulmonary embolism","volume":"303","author":"Sharma","year":"1980","journal-title":"New England Journal of Medicine"},{"issue":"12","key":"10.1002\/14651858.CD004437.pub5-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1001\/jama.1970.03180120035007","article-title":"Urokinase pulmonary embolism trial. Phase 1 results: a co-operative study","volume":"214","author":"UPET","year":"1970","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD004437.pub5-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ehj.2011.09.006","article-title":"Efficacy and safety of high dose versus low dose streptokinase for treatment of submassive pulmonary embolism","volume":"63","author":"Abdelsamad","year":"2011","journal-title":"Egyptian Heart Journal"},{"issue":"4","key":"10.1002\/14651858.CD004437.pub5-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/00001721-199706000-00002","article-title":"Fibrinogenolysis and thrombin generation after reduced dose bolus or conventional rt-PA for pulmonary embolism. The Coagulation Project Investigators of the Bolus Alteplase Pulmonary Embolism Group","volume":"8","author":"Agnelli","year":"1997","journal-title":"Blood Coagulation and Fibrinolysis"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD004437.pub5-BIB0031|cit31","first-page":"34","article-title":"The bleeding risk in thrombolysed patients with intermediary-high risk pulmonary embolism","volume":"19","author":"Alexandru Ion","year":"2017","journal-title":"European Journal of Heart Failure"},{"key":"10.1002\/14651858.CD004437.pub5-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.amjmed.2016.11.027","article-title":"Treatment of right heart thrombi associated with acute pulmonary embolism","volume":"130","author":"Barrios","year":"2017","journal-title":"American Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD004437.pub5-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1161\/01.CIR.50.6.1070","article-title":"The urokinase-streptokinase pulmonary embolism trial (phase II) results","volume":"50","author":"Bell","year":"1974","journal-title":"Circulation"},{"issue":"1","key":"10.1002\/14651858.CD004437.pub5-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1055\/s-0038-1647911","article-title":"Streptokinase and urokinase in the treatment of pulmonary thromboemboli; from a national co-operative study","volume":"35","author":"Bell","year":"1976","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD004437.pub5-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1177\/153857447701100607","article-title":"Thrombolytic therapy: differences between streptokinase and urokinase","volume":"11","author":"Bell","year":"1977","journal-title":"Vascular Surgery"},{"issue":"5","key":"10.1002\/14651858.CD004437.pub5-BIB0036|cit36","first-page":"454","article-title":"Treatment of massive pulmonary embolism by tenecteplase","volume":"62","author":"Bhardwaj","year":"2010","journal-title":"Indian Heart Journal"},{"key":"10.1002\/14651858.CD004437.pub5-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s11239-018-1608-3","article-title":"Catheter-directed, ultrasound-facilitated fibrinolysis in obese patients with massive and submassive pulmonary embolism","volume":"45","author":"Carroll","year":"2018","journal-title":"Journal of Thrombosis and Thrombolysis"},{"key":"10.1002\/14651858.CD004437.pub5-BIB0038|cit38","unstructured":"Charbonnier B Raynaud P Griguier P Brochier M Potentializing effects of a defibrillating agent on therapeutic thrombolysis in pulmonary embolism Archives des Maladies du Coeur et des Vaisseaux 1984 1426"},{"key":"10.1002\/14651858.CD004437.pub5-BIB0039|cit39","doi-asserted-by":"crossref","unstructured":"Chen Z Evaluation of effect of rt-PA therapy and different dose in acute pulmonary embolism [Abstract]. American Thoracic Society 2009 International Conference; 2009 May 15-20; San Diego American Journal of Respiratory and Critical Care Medicine 2009 A3294","DOI":"10.1164\/ajrccm-conference.2009.179.1_MeetingAbstracts.A3294"},{"key":"10.1002\/14651858.CD004437.pub5-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1177\/1531003509359311","article-title":"The ATTRACT trial: rationale for early intervention for iliofemoral DVT","volume":"21","author":"Comerota","year":"2009","journal-title":"Perspectives in Vascular Surgery and Endovascular Therapy"},{"issue":"3","key":"10.1002\/14651858.CD004437.pub5-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0002-9610(73)80114-X","article-title":"The urokinase pulmonary embolism trial","volume":"126","author":"Takats","year":"1973","journal-title":"American Journal of Surgery"},{"key":"10.1002\/14651858.CD004437.pub5-BIB0042|cit42","unstructured":"Erkan L Findik S Atici AG Uzun O Thrombolytic therapy in massive pulmonary thromboembolism European Respiratory Journal 2002 237s"},{"issue":"4","key":"10.1002\/14651858.CD004437.pub5-BIB0043|cit43","first-page":"435","article-title":"Treatment of acute pulmonary embolism with urokinase compared with the combination plasminogen-urokinase. 67 cases","volume":"79","author":"Francois","year":"1986","journal-title":"Archives des Maladies du Coeur et des Vaisseaux"},{"key":"10.1002\/14651858.CD004437.pub5-BIB0044|cit44","first-page":"292","article-title":"TPA versus urokinase in acute pulmonary embolism: results of a randomized controlled trial","volume":"27","author":"Goldhaber","year":"1989","journal-title":"Vasa - Supplementum"},{"issue":"5 Suppl","key":"10.1002\/14651858.CD004437.pub5-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"282S","DOI":"10.1378\/chest.95.5.282S","article-title":"Tissue plasminogen activator in acute pulmonary embolism","volume":"95","author":"Goldhaber","year":"1989","journal-title":"Chest"},{"issue":"1","key":"10.1002\/14651858.CD004437.pub5-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/0735-1097(92)90132-7","article-title":"Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: a randomized controlled multicenter trial","volume":"20","author":"Goldhaber","year":"1992","journal-title":"Journal of the American College of Cardiology"},{"issue":"3","key":"10.1002\/14651858.CD004437.pub5-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1378\/chest.106.3.718","article-title":"Reduced dose bolus alteplase versus conventional alteplase infusion for pulmonary embolism thrombolysis: an international multicenter randomised trial","volume":"106","author":"Goldhaber","year":"1994","journal-title":"Chest"},{"key":"10.1002\/14651858.CD004437.pub5-BIB0048|cit48","unstructured":"IRCT201104245625N2 Comparative efficacy and complications of two-hour versus 24-hour regimen of streptokinase in acute pulmonary embolism In Tehran Heart Center en.irct.ir\/trial\/6153"},{"key":"10.1002\/14651858.CD004437.pub5-BIB0049|cit49","first-page":"667","article-title":"Thrombolytic treatment of acute pulmonary thromboembolism: comparison between catheter-directed thrombolysis and venous thrombolysis","volume":"21","author":"Jin","year":"2012","journal-title":"Journal of Interventional Radiology"},{"key":"10.1002\/14651858.CD004437.pub5-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1111\/crj.12751","article-title":"Efficacy and safety of low-dose urokinase for the treatment of hemodynamically stable AECOPD patients with acute pulmonary thromboembolism","volume":"12","author":"Jing","year":"2018","journal-title":"Clinical Respiratory Journal"},{"issue":"8","key":"10.1002\/14651858.CD004437.pub5-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S0002-9149(98)00513-X","article-title":"Comparison of alteplase versus heparin for resolution of major pulmonary embolism","volume":"82","author":"Konstantinides","year":"1998","journal-title":"American Journal of Cardiology"},{"key":"10.1002\/14651858.CD004437.pub5-BIB0052|cit52","first-page":"354","article-title":"Surgical embolectomy compared to thrombolysis in acute pulmonary embolism: Morbidity and mortality","volume":"51","author":"Lehnert","year":"2017","journal-title":"European Journal of Cardio-thoracic Surgery"},{"issue":"19","key":"10.1002\/14651858.CD004437.pub5-BIB0053|cit53","first-page":"1343","article-title":"Management of acute massive with interventional techniques","volume":"92","author":"Liu","year":"2012","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"5","key":"10.1002\/14651858.CD004437.pub5-BIB0054|cit54","first-page":"721","article-title":"Changes in the plasma fibrinolytic system during urokinase therapy: comparison of tissue culture urokinase with urinary source urokinase in patients with pulmonary embolism","volume":"92","author":"Marder","year":"1978","journal-title":"Journal of Laboratory Clinical Medicine"},{"issue":"7","key":"10.1002\/14651858.CD004437.pub5-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1093\/oxfordjournals.eurheartj.a015410","article-title":"Streptokinase vs alteplase in massive pulmonary embolism. A randomized trial assessing right heart haemodynamics and pulmonary vascular obstruction","volume":"18","author":"Meneveau","year":"1997","journal-title":"European Heart Journal"},{"issue":"5","key":"10.1002\/14651858.CD004437.pub5-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0735-1097(98)00068-0","article-title":"Comparative efficacy of a two-hour regimen of streptokinase versus alteplase in acute massive pulmonary embolism: immediate clinical and hemodynamic outcome and one-year follow-up","volume":"31","author":"Meneveau","year":"1998","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD004437.pub5-BIB0057|cit57","first-page":"339","article-title":"Comparison of the effect of an intravenous infusion of urokinase or alteplase on total pulmonary resistance in acute massive pulmonary embolism. A European, multi-center, double-blind study","volume":"29","author":"Meyer","year":"1992","journal-title":"Intensivmedizin und Notfallmedizin"},{"issue":"2","key":"10.1002\/14651858.CD004437.pub5-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0735-1097(92)90472-Y","article-title":"Effects of intravenous urokinase versus alteplase on total pulmonary resistance in acute massive pulmonary embolism: a European multicenter double-blind trial. The European Cooperative Study Group for Pulmonary Embolism","volume":"19","author":"Meyer","year":"1992","journal-title":"Journal of the American College of Cardiology"},{"issue":"2","key":"10.1002\/14651858.CD004437.pub5-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1136\/bmj.2.5763.681","article-title":"Comparison of streptokinase and heparin in treatment of isolated acute massive pulmonary embolism","volume":"763","author":"Miller","year":"1971","journal-title":"British Medical Journal"},{"issue":"7","key":"10.1002\/14651858.CD004437.pub5-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/MBC.0b013e3282e38e61","article-title":"Time course of platelet aggregation during thrombolytic treatment of massive pulmonary embolism","volume":"18","author":"Muhl","year":"2007","journal-title":"Blood Coagulation and Fibrinolysis"},{"key":"10.1002\/14651858.CD004437.pub5-BIB0061|cit61","unstructured":"NCT00680628 Randomized trial of tenecteplase to treat severe submassive pulmonary embolism http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00680628?cond=pulmonary+embolism&rank=42 (accessed January 2015)"},{"key":"10.1002\/14651858.CD004437.pub5-BIB0062|cit62","unstructured":"NCT00968929 Recombinant streptokinase versus urokinase in pulmonary embolism in China (RESUPEC) clinicaltrials.gov\/ct2\/show\/NCT00968929"},{"key":"10.1002\/14651858.CD004437.pub5-BIB0063|cit63","unstructured":"NCT01956955 Comparison of low-molecular-weight heparin (LMWH) and unfractionated heparin (UFH) in combination with thrombolytic treatment of acute massive pulmonary thromboembolism clinicaltrials.gov\/ct2\/show\/NCT01956955"},{"issue":"4","key":"10.1002\/14651858.CD004437.pub5-BIB0064|cit64","first-page":"445","article-title":"Hemodynamic course during fibrinolysis in severe pulmonary embolism","volume":"79","author":"Ohayon","year":"1986","journal-title":"Archives des Maladies du Coeur et des Vaisseaux"},{"issue":"1","key":"10.1002\/14651858.CD004437.pub5-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000196642","article-title":"Resolution of pulmonary embolism: effect of therapy and putative age of emboli","volume":"64","author":"Palla","year":"1997","journal-title":"Respiration"},{"key":"10.1002\/14651858.CD004437.pub5-BIB0066|cit66","first-page":"3074","article-title":"Changes of blood coagulative and fibrinolytic system and function of pulmonary vascular endothelium after therapy in patients with acute pulmonary thromboembolism","volume":"87","author":"Pang","year":"2007","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"38","key":"10.1002\/14651858.CD004437.pub5-BIB0067|cit67","first-page":"1727","article-title":"Diagnostic approaches and results in the medical treatment of pulmonary thromboembolism","volume":"76","author":"Prandoni","year":"1985","journal-title":"Minerva Medica"},{"issue":"7","key":"10.1002\/14651858.CD004437.pub5-BIB0068|cit68","first-page":"773","article-title":"Multicenter study of 2 urokinase protocols in severe pulmonary embolism","volume":"77","author":"Research Group on Urokinase and Pulmonary Embolism","year":"1984","journal-title":"Archives des Maladies du Coeur et des Vaisseaux"},{"issue":"Suppl 38","key":"10.1002\/14651858.CD004437.pub5-BIB0069|cit69","first-page":"239s","article-title":"Massive pulmonary embolism and thrombolysis in the first week after major surgery","volume":"20","author":"Saponjski","year":"2002","journal-title":"European Respiratory Journal"},{"issue":"3","key":"10.1002\/14651858.CD004437.pub5-BIB0070|cit70","first-page":"464","article-title":"The phase II urokinase-streptokinase pulmonary embolism trial: a national cooperative study","volume":"33","author":"Sasahara","year":"1975","journal-title":"Thrombosis et Diathesis Haemorrhagica"},{"issue":"2","key":"10.1002\/14651858.CD004437.pub5-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1177\/1358836X0000500205","article-title":"Long-term benefit of thrombolytic therapy in patients with pulmonary embolism","volume":"5","author":"Sharma","year":"2000","journal-title":"Vascular Medicine"},{"issue":"3","key":"10.1002\/14651858.CD004437.pub5-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1378\/chest.106.3.712","article-title":"Hemodynamic effects of bolus vs 2-h infusion of alteplase in acute massive pulmonary embolism. A randomized controlled multicenter trial","volume":"106","author":"Sors","year":"1994","journal-title":"Chest"},{"issue":"7","key":"10.1002\/14651858.CD004437.pub5-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0002-8703(99)70243-7","article-title":"Hemodynamic effects of double bolus reteplase versus alteplase infusion in massive pulmonary embolism","volume":"138","author":"Tebbe","year":"1999","journal-title":"American Heart Journal"},{"key":"10.1002\/14651858.CD004437.pub5-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1160\/TH08-10-0638","article-title":"Desmoteplase in acute massive pulmonary thromboembolism","volume":"101","author":"Tebbe","year":"2009","journal-title":"Thrombosis and Haemostasis"},{"issue":"1","key":"10.1002\/14651858.CD004437.pub5-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/oxfordjournals.eurheartj.a062154","article-title":"The UKEP Study: multicentre clinical trial on two local regimes of urokinase in massive pulmonary embolism","volume":"8","author":"The UKEP Study Research Group","year":"1987","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD004437.pub5-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1001\/jama.1974.03230500024021","article-title":"Urokinase streptokinase embolism trial. Phase 2 results. A co-operative study","volume":"229","author":"The Urokinase Pulmonary Embolism Trial Study Froup","year":"1974","journal-title":"Journal of the American Medical Association"},{"issue":"2","key":"10.1002\/14651858.CD004437.pub5-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1161\/01.CIR.77.2.353","article-title":"Intravenous and intrapulmonary recombinant tissue-type plasminogen activator in the treatment of acute massive pulmonary embolism","volume":"77","author":"Verstraete","year":"1988","journal-title":"Circulation"},{"issue":"31","key":"10.1002\/14651858.CD004437.pub5-BIB0078|cit78","first-page":"2161","article-title":"The clinical features of 516 patients with acute pulmonary thromboembolism","volume":"86","author":"Wang","year":"2006","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1002\/14651858.CD004437.pub5-BIB0079|cit79","first-page":"371","article-title":"Changes in deep venous thrombosis after thrombolytic anticoagulant therapies in acute pulmonary thromboembolism","volume":"48","author":"Yang","year":"2009","journal-title":"Chinese Journal of Internal Medicine"},{"key":"10.1002\/14651858.CD004437.pub5-BIB0080|cit80","first-page":"A137","article-title":"The echocardiographic changes of pre and after treatments of recombinant streptokinase and urokinase on pulmonary embolism [Abstract]","volume":"14","author":"Wang","year":"2009","journal-title":"Respirology"},{"key":"10.1002\/14651858.CD004437.pub5-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1378\/chest.09-0765","article-title":"Efficacy and safety of low dose recombinant tissue-type plasminogen activator for the treatment of acute pulmonary thromboembolism: a randomized, multicenter, controlled trial","volume":"137","author":"Wang","year":"2010","journal-title":"Chest"},{"key":"10.1002\/14651858.CD004437.pub5-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/1465-9921-10-128","article-title":"Efficacy and safety of 2-hour urokinase regime in acute pulmonary embolism: a randomized controlled trial [Abstract]","volume":"10","author":"Wang","year":"2009","journal-title":"Respiratory Research"},{"key":"10.1002\/14651858.CD004437.pub5-BIB0083|cit83","first-page":"103","article-title":"An economic evaluation of low dose recombinant human tissue-type plasminogen activator for the treatment of acute pulmonary thromboembolism","volume":"90","author":"Wu","year":"2010","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1002\/14651858.CD004437.pub5-BIB0084|cit84","first-page":"3062","article-title":"Effect of 50 mg alteplase to intermediate-risk pulmonary embolism with right ventricular dysfunction","volume":"96","author":"Xu","year":"2016","journal-title":"Chung Hua I Hsueh Tsa Chih"},{"key":"10.1002\/14651858.CD004437.pub5-BIB0085|cit85","first-page":"544s","article-title":"Comparison of local and systemic thrombolytic treatment for acute massive pulmonary embolism [Abstract]","volume":"30","author":"Yang","year":"2007","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD004437.pub5-BIB0086|cit86","first-page":"309","article-title":"Efficacy and safety of two-hour regimen of recombinant streptokinase versus urokinase in massive and submassive pulmonary embolism [Abstract]","volume":"16","author":"Yang","year":"2011","journal-title":"Respirology"},{"key":"10.1002\/14651858.CD004437.pub5-BIB0087|cit87","first-page":"1628-34","article-title":"Comparison of long-term outcomes of 50 and 100 mg rt-PA in the management of acute pulmonary thromboembolism","volume":"12","author":"Yilmazel","year":"2018","journal-title":"Clinical Respiratory Journal"},{"key":"10.1002\/14651858.CD004437.pub5-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s11239-007-0087-8","article-title":"Value of transthoracic echocardiography in therapy regimens evaluation in pulmonary embolism","volume":"26","author":"Zhu","year":"2008","journal-title":"Journal of Thrombosis and Thrombolysis"},{"key":"10.1002\/14651858.CD004437.pub5-BIB0089|cit89","unstructured":"EUCTR2017-005075-91 Low dose thrombolysis, ultrasound assisted thrombolysis or heparin for intermediate high risk pulmonary embolism clinicaltrialsregister.eu\/ctr-search\/trial\/2017-005075-91\/DK"},{"key":"10.1002\/14651858.CD004437.pub5-BIB0090|cit90","unstructured":"EudraCT 2005-001070-27 Open, randomised, monosite pilot trial for comparison of thrombolytic efficacy of tenecteplase and alteplase in patients with acute pulmonary embolism clinicaltrialsregister.eu\/ctr-search\/search?query=eudract_number:2005-001070-27"},{"key":"10.1002\/14651858.CD004437.pub5-BIB0091|cit91","unstructured":"NCT01531829 Low dose Rt-PA for acute normotensive pulmonary embolism with RVD clinicaltrials.gov\/ct2\/show\/NCT01531829"},{"key":"10.1002\/14651858.CD004437.pub5-BIB0092|cit92","unstructured":"NCT02604238 Efficacy and safety of half dose alteplase added to heparin, in patients with moderate pulmonary embolism (MONALYSE) clinicaltrials.gov\/ct2\/show\/NCT02604238"},{"key":"10.1002\/14651858.CD004437.pub5-BIB0093|cit93","unstructured":"NCT03218410 Surgical pulmonary embolectomy versus catheter-directed thrombolysis in the treatment of pulmonary embolism: a non-inferiority study (Lungembolism) clinicaltrials.gov\/ct2\/show\/NCT03218410"},{"issue":"1","key":"10.1002\/14651858.CD004437.pub5-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0300-9572(94)90054-X","article-title":"Bolus injection of thrombolytic agents during cardiopulmonary resuscitation for massive pulmonary embolism","volume":"28","author":"Bottiger","year":"1994","journal-title":"Resuscitation"},{"key":"10.1002\/14651858.CD004437.pub5-BIB0095|cit95","first-page":"1039","article-title":"Streptokinase and pulmonary embolism","volume":"2","author":"Browse","year":"1962","journal-title":"The Lancet"},{"issue":"8","key":"10.1002\/14651858.CD004437.pub5-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2147\/PPA.S56280","article-title":"Systematic review and meta-analysis for thrombolysis treatment in patients with acute submassive pulmonary embolism","volume":"28","author":"Cao","year":"2014","journal-title":"Patient Preference and Adherence"},{"issue":"23","key":"10.1002\/14651858.CD004437.pub5-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1001\/jama.2014.5990","article-title":"Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: a meta-analysis","volume":"311","author":"Chatterjee","year":"2014","journal-title":"Journal of the American Medical Association"},{"issue":"22","key":"10.1002\/14651858.CD004437.pub5-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.5694\/j.1326-5377.1969.tb107628.x","article-title":"Streptokinase therapy in acute major pulmonary embolism","volume":"2","author":"Chesterman","year":"1969","journal-title":"Medical Journal of Australia"},{"issue":"17","key":"10.1002\/14651858.CD004437.pub5-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.2146\/ajhp170357","article-title":"Clinical update on thrombolytic use in pulmonary embolism: a focus on intermediate-risk patients","volume":"75","author":"Eberle","year":"2018","journal-title":"American Journal of Health-system Pharmacy"},{"issue":"5","key":"10.1002\/14651858.CD004437.pub5-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.thromres.2015.09.012","article-title":"Thrombolysis for acute intermediate-risk pulmonary embolism: a meta-analysis","volume":"136","author":"Gao","year":"2015","journal-title":"Thrombosis Research"},{"issue":"5","key":"10.1002\/14651858.CD004437.pub5-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/0002-8703(68)90161-0","article-title":"Urokinase therapy in pulmonary thromboembolism","volume":"76","author":"Genton","year":"1968","journal-title":"American Heart Journal"},{"issue":"8606","key":"10.1002\/14651858.CD004437.pub5-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(88)92354-9","article-title":"Randomised controlled trial of recombinant tissue plasminogen activator versus urokinase in the treatment of acute pulmonary embolism","volume":"2","author":"Goldhaber","year":"1988","journal-title":"The Lancet"},{"issue":"15","key":"10.1002\/14651858.CD004437.pub5-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1056\/NEJMp020107","article-title":"Thrombolysis for pulmonary embolism","volume":"347","author":"Goldhaber","year":"2002","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD004437.pub5-BIB0104|cit104","unstructured":"McMaster University (developed by Evidence Prime) GRADEpro GDT 2015"},{"issue":"12","key":"10.1002\/14651858.CD004437.pub5-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s11886-018-1084-6","article-title":"Short- and long-term mortality risk after acute pulmonary embolism","volume":"20","author":"Gupta","year":"2018","journal-title":"Current Cardiology Reports"},{"key":"10.1002\/14651858.CD004437.pub5-BIB0106|cit106","doi-asserted-by":"crossref","unstructured":"Hepburn-Brown M Darvall J Hammerschlag G Acute pulmonary embolism: a concise review of diagnosis and management Internal Medicine Journal 2018 10.1111\/imj.14145","DOI":"10.1111\/imj.14145"},{"key":"10.1002\/14651858.CD004437.pub5-BIB0107|cit107","unstructured":"Higgins JP Green S editor(s) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"6","key":"10.1002\/14651858.CD004437.pub5-BIB0108|cit108","first-page":"488","article-title":"Comparison of the effects of streptokinase and heparin on the early rate of resolution of major pulmonary embolism","volume":"104","author":"Hirsh","year":"1971","journal-title":"Canadian Medical Association Journal"},{"issue":"6","key":"10.1002\/14651858.CD004437.pub5-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1161\/01.CIR.42.6.979","article-title":"Treatment of pulmonary embolism with urokinase. Results of clinical trial (phase 1)","volume":"42","author":"Hyers","year":"1970","journal-title":"Circulation"},{"issue":"16","key":"10.1002\/14651858.CD004437.pub5-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1161\/CIR.0b013e318214914f","article-title":"Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association","volume":"123","author":"Jaff","year":"2011","journal-title":"Circulation"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD004437.pub5-BIB0111|cit111","first-page":"104","article-title":"Submassive and massive pulmonary embolism: a target for thrombolytic therapy?","volume":"82","author":"Konstantinides","year":"1999","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD004437.pub5-BIB0112|cit112","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"1","key":"10.1002\/14651858.CD004437.pub5-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.thromres.2014.04.007","article-title":"Recombinant tissue plasminogen activator for hemodynamically stable patients experiencing an acute pulmonary embolism: a meta-analysis","volume":"134","author":"Liu","year":"2014","journal-title":"Thrombosis Research"},{"issue":"10","key":"10.1002\/14651858.CD004437.pub5-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/eurheartj\/ehu218","article-title":"Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis","volume":"36","author":"Marti","year":"2014","journal-title":"European Heart Journal"},{"issue":"4","key":"10.1002\/14651858.CD004437.pub5-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1378\/chest.129.4.1043","article-title":"Management of unsuccessful thrombolysis in acute massive pulmonary embolism","volume":"129","author":"Meneveau","year":"2006","journal-title":"Chest"},{"issue":"7","key":"10.1002\/14651858.CD004437.pub5-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1111\/jth.12608","article-title":"Impact of the efficacy of thrombolytic therapy on the mortality of patients with acute submassive pulmonary embolism: a meta-analysis","volume":"12","author":"Nakamura","year":"2014","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD004437.pub5-BIB0117|cit117","unstructured":"National Institute for Health and Clinical Excellence Venous thromboembolic diseases: the management of venous thromboembolic diseases and the role of thrombophilia testing nice.org.uk\/guidance\/cg144"},{"issue":"1","key":"10.1002\/14651858.CD004437.pub5-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1001\/archinte.167.1.74","article-title":"Effectiveness and cost-effectiveness of thrombolysis in submassive pulmonary embolism","volume":"167","author":"Perlroth","year":"2007","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD004437.pub5-BIB0119|cit119","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"22","key":"10.1002\/14651858.CD004437.pub5-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1056\/NEJM196711302772203","article-title":"Urokinase therapy in clinical pulmonary embolism. A new thrombolytic agent","volume":"277","author":"Sasahara","year":"1967","journal-title":"New England Journal of Medicine"},{"issue":"2 Suppl","key":"10.1002\/14651858.CD004437.pub5-BIB0121|cit121","first-page":"7","article-title":"The urokinase pulmonary embolism trial: a national co-operative study","volume":"47","author":"Sasahara","year":"1973","journal-title":"Circulation"},{"issue":"3","key":"10.1002\/14651858.CD004437.pub5-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1001\/jama.1967.03130160089019","article-title":"Urokinase for the treatment of acute pulmonary thromboembolism","volume":"202","author":"Sautter","year":"1967","journal-title":"Journal of the American Medical Association"},{"issue":"1","key":"10.1002\/14651858.CD004437.pub5-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1148\/radiol.2017151978","article-title":"Stratification, imaging, and management of acute massive and submassive pulmonary embolism","volume":"284","author":"Sista","year":"2017","journal-title":"Radiology"},{"issue":"3","key":"10.1002\/14651858.CD004437.pub5-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1053\/j.tvir.2017.07.005","article-title":"Systemic thrombolysis for pulmonary embolism: who and how","volume":"20","author":"Tapson","year":"2017","journal-title":"Techniques in Vascular and Interventional Radiology"},{"issue":"22","key":"10.1002\/14651858.CD004437.pub5-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1056\/NEJM196711302772202","article-title":"Urokinase in pulmonary embolism","volume":"277","author":"Tow","year":"1967","journal-title":"New England Journal of Medicine"},{"issue":"7","key":"10.1002\/14651858.CD004437.pub5-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"885","DOI":"10.2169\/internalmedicine.31.885","article-title":"The role of recombinant human tissue-type plasminogen activator in the treatment of acute pulmonary thromboembolism","volume":"31","author":"Yamasawa","year":"1992","journal-title":"Internal Medicine"},{"issue":"3","key":"10.1002\/14651858.CD004437.pub5-BIB0127|cit127","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004437","article-title":"Thrombolytic therapy for pulmonary embolism","author":"Dong","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD004437.pub5-BIB0128|cit128","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004437.pub2","article-title":"Thrombolytic therapy for pulmonary embolism","author":"Dong","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD004437.pub5-BIB0129|cit129","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004437.pub3","article-title":"Thrombolytic therapy for pulmonary embolism","author":"Dong","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9","key":"10.1002\/14651858.CD004437.pub5-BIB0130|cit130","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004437.pub4","article-title":"Thrombolytic therapy for pulmonary embolism","author":"Hao","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd004437.pub6","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T00:00:00Z","timestamp":1618444800000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD004437.pub5\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T15:25:45Z","timestamp":1775316345000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD004437.pub5"}},"subtitle":[],"editor":[{"name":"Cochrane Vascular Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,12,18]]},"references-count":130,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd004437.pub5","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,18]]}}}